Talmapimod
Talmapimod (SCIO-469) is a potent, orally bioavailable, and highly selective ATP-competitive inhibitor of p38α MAP kinase (IC50 = 9 nM) . It demonstrates significant selectivity over p38β and other kinases. This compound has been utilized in research to investigate p38α's role in inflammatory pathways in both cellular and animal models.
Product Specifications
CAS Number
309913-83-5
Product Name Alternative
Cells, cytotoxicity, Hsp27, Inhibitor, inhibit, myeloma, multiple, p38 MAPK, p38α, p38β, p38MAPK, phosphorylation, Talmapimod, SCIO 469, SCIO469, SCIO-469, tumor
Field of Research
Signal Transduction
Purity
98.00% (May vary between batches)
Solubility
DMSO:95 mg/mL (185.19 mM)
Smiles
C[C@H]1CN ([C@H] (C) CN1Cc1ccc (F) cc1) C (=O) c1cc2c (cn (C) c2cc1Cl) C (=O) C (=O) N (C) C
Molecular Formula
C27H30ClFN4O3
Molecular Weight
513
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
More Discoveries
Explore Other Products
Browse additional items from our catalog
![Mouse Monoclonal Glutamine Synthetase Antibody (8D7) [DyLight 488]](https://cdn.genprice.uk/genprice/uk/genprice4.webp)
NBP2-60240G 0.1 mL
Mouse Monoclonal Glutamine Synthetase Antibody (8D7) [DyLight 488]
Sign In for Pricing
View Details 
302694-HRP 200 µL
RAPGEF1 (Rap Guanine Nucleotide Exchange Factor 1, CRK SH3-Binding GNRP, Guanine Nucleotide-Releasing Factor 2, Protein C3G, RAPGEF1, GRF2) (HRP) discontinued
Sign In for Pricing
View Details